搜索筛选:
搜索耗时1.7873秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[期刊论文] 作者:Shangqin Liu,Chengsi Gui, 来源:肿瘤学与转化医学:英文版 年份:2021
Chimeric antigen receptor(CAR)T-cell therapy is an effective new treatment strategy for hematologic malignancies.The success of CAR T-cell therapy in treating l...
[期刊论文] 作者:Shangqin Liu,Chengsi Gui, 来源:肿瘤学与转化医学(英文) 年份:2021
Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment strategy for hematologic malignancies. The success of CAR T-cell therapy in treatin...
[期刊论文] 作者:Gang Zhou,Xiangyu Meng,Shangqin Liu, 来源:肿瘤学与转化医学(英文) 年份:2020
Objective This case-control study aimed to investigate whether diabetes mellitus (DM), hypertension, hyperlipidemia, and chronic viral hepatitis are risk factor...
[会议论文] 作者:Xiaoping Liu,xiangyu Meng,Kaili Li,Qing Liang,Li He,Shangqin Liu, 来源:The 35th World Congress of the International Society of Hema 年份:2014
[会议论文] 作者:Xiaoping Liu,xiangyu Meng,Kaili Li,Qing Liang,Li He,Shangqin Liu, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Objective The aim of this meta-analysis of data from phase Ⅲ studies is to characterize efficacy and safety of bortezomib-based versus nonbortezomib-based post-transplantation therapy in patients with...
相关搜索: